Category: HypertensionSyndicate content

Renal denervation: Boston Scientific launches new Vessix trial

April 17, 2015 by Brad Perriello

Boston Scientific launches a clinical trial of its Vessix renal denervation device in treating hypertension, aiming to separate its effects from drug therapy for high blood pressure.

Renal denervation: Boston Scientific launches new Vessix trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ReCor Medical raises $15M for ultrasound RDN

April 13, 2015 by Mark Hollmer

ReCor Medical raises a $15 million Series D financing for a planned U.S. study of its ultrasound renal denervation device.

ReCor Medical raises $15M for ultrasound RDN

A Japanese healthcare conglomerate is the lead investor ReCor Medical's $15 million Series D round ReCor plans to use to back a U.S. clinical trial of its ultrasound renal denervation device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic takes another crack at renal denervation

April 1, 2015 by Brad Perriello

Medtronic launches a new clinical trial examining renal denervation as a treatment for hypertension, aiming to settle the 'confounding factors' that led to the failure of its Symplicity-3 trial.

Medtronic takes another crack at renal denervation

Renal Denervation: Medtronic taking another shot at drug-resistant hypertension

February 20, 2015 by Mark Hollmer

Medtronic is taking another shot at renal denervation to treat drug-resistant hypertension, a year after a pivotal trial for its key product in the space failed to meet its efficacy endpoint.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hypertension: Stealthy Verve Medical raises $2m for RDN device

February 3, 2015 by Mark Hollmer

Verve Medical raises just less than $2 million in an equity offering for its renal denervation device.

Hypertension: Stealthy Verve Medical raises $2m for RDN device

Stealthy renal denervation startup Verve Medical raised close to $2 million, according to a regulatory filing, with funding likely slated to help support clinical trials.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: Rox Medical's Coupler hypertension stent fares well in pivotal trial

January 28, 2015 by Mark Hollmer

Rox Medical's stent-like Coupler implant, designed to treat resistant hypertension, fares well in a pivotal trial as the company gears up for a run at an investigational device exemption from the FDA.

Vascular Dynamics secures $17m Series B round

January 13, 2015 by Val Kennedy

Vascular Dynamics secures a $17 million Series B round to fund clinical trials for its device to treat drug-resistant hypertension.

Vascular Dynamics secures $17m Series B round

Vascular Dynamics said it secured $16.85 million in Series B financing to fund clinical trials for its device to treat drug-resistant hypertension.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.